3-Ethynylaniline CAS 54060-30-9 Maʻemaʻe >99.0% (GC) Erlotinib Hydrochloride Intermediate

ʻO ka wehewehe pōkole:

Inoa Kemika: 3-Ethynylaniline

Nā huaʻōlelo like: 3-Aminophenylacetylene

CAS: 54060-30-9

Maʻemaʻe: >99.0% (GC)

ʻAno: Melemele māmā a hiki i ka wai ʻulaʻula

Ka waena o Erlotinib Hydrochloride (CAS: 183319-69-9)

Hoʻokaʻaʻike: Kauka Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

ʻO ka mea hana alakaʻi a me ka mea hoʻolako o Erlotinib Hydrochloride Intermediates
Erlotinib Hydrochloride CAS 183319-69-9
3-Ethynylaniline CAS 54060-30-9
6,7-Bis(2-Methoxyethoxy)-3H-Quinazolin-4-one CAS 179688-29-0
Please contact: alvin@ruifuchem.com

Na Waiwai Kemika:

Inoa Kimia	3-Ethynylaniline
Nā huaʻōlelo like	3-Aminophenylacetylene
Helu CAS	54060-30-9
Helu CAT	RF-PI2241
Kūlana Kūʻai	I loko o ka waihona, ka mana hana 50MT / mahina
ʻĀpana Molekala	C8H7N
Kaumaha Molecular	117.15
Pilikino	Paʻi Lewa, Māmā
Lae paila	120 ℃/20 mmHg
Hiki i ka wai	ʻAʻole hiki ke hoʻonā i ka wai
Brand	Kemika Ruifu

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Melemele māmā i ka wai ʻulaʻula
Maʻemaʻe / Kaʻina Hanana	>99.0% (GC)
Wai na Karl Fischer	<0.50%
Koena ma ka Ignition	<0.20%
Huina paumaele	<1.00%
Kaumaha kiko (20/20 ℃)	1.041~1.048
Hōʻike Hōʻikeʻike N20/D	1.614~1.6195
Infrared Spectrum	Kūlike i ka hoʻolālā
Proton NMR Spectrum	Kūlike i ka hoʻolālā
Kūlana hoʻāʻo	Kūlana ʻoihana
Hoʻohana	Lapaʻau Kūwaena;ʻO Erlotinib Hydrochloride Intermediate

Pūʻolo a me ka waiho ʻana:

Pūʻolo: Fluorinated Bottle, 25kg/Drum, a i ʻole e like me ka makemake o ka mea kūʻai aku

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai

Pono:

FAQ:

Noi:

Hoʻohana ʻia ʻo 3-Ethynylaniline, ʻike ʻia ʻo 3-Aminophenylacetylene (CAS: 54060-30-9) ma ke ʻano he lāʻau waena.ʻO 3-Ethynylaniline kahi mea waena o Erlotinib Hydrochloride (CAS: 183319-69-9).ʻO Erlotinib Hydrochloride kahi mole liʻiliʻi tyrosine kinase inhibitor e hana hoʻohuli i ka epidermal growth receptors, kahi hydrochloride o erlotinib, kahi lāʻau i hoʻopaʻa ʻia i ka molecular.Ua ʻae ka US Food and Drug Administration (FDA) i ka erlotinib (Tarceva) i hui pū ʻia me ka gemcitabine ma ke ʻano he lāʻau lapaʻau mua no ka maʻi maʻi pancreatic kūloko a me ka metastatic.Hoʻohana nui ʻia ia ma ke ʻano he lāʻau lapaʻau ʻelua a ʻekolu paha no ka maʻi maʻi maʻi maʻi maʻi maʻi pancreatic a i ʻole metstatic non-small cell lung cancer (NSCLC).Hoʻohana ʻia ia e like me ka tyrosine inhibitor no ka mālama NSCLC.Ua ʻae ʻia ʻo Erlotinib Hydrochloride, kahi quinazoline i loaʻa i ka moleki liʻiliʻi o ka epidermal growth receptor (EDGFR) tyrosine kinase, i Nowemapa, 2004, no ka mālama ʻana i ka maʻi maʻi maʻi maʻi ʻaʻole liʻiliʻi liʻiliʻi.